Syndactyly type 6
disease diseaseOn this page
Also known as mitten handsyndactyly, mitten typeunilateral syndactyly of digits 2-5
Summary
Syndactyly type 6 (MONDO:0017460) is a disease. A subtype of non-syndromic syndactyly — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | syndactyly type 6 |
| Mondo ID | MONDO:0017460 |
| Orphanet | 295012 |
| ICD-11 | 2105806379 |
| SNOMED CT | 763624007 |
| UMLS | C4706525 |
| MedGen | 1635950 |
| GARD | 0021201 |
| Is cancer (heuristic) | no |
Also known as: mitten hand · syndactyly, mitten type · unilateral syndactyly of digits 2-5
Disease family
This is a subtype of non-syndromic syndactyly. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › syndactyly › non-syndromic syndactyly › syndactyly type 6
Related subtypes (7): non-syndromic synpolydactyly, syndactyly type 1, syndactyly type 3, syndactyly type 4, syndactyly type 5, syndactyly type 8, mesoaxial synostotic syndactyly with phalangeal reduction
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.